Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 352 Neoplasm Metastasis 31 Stomach Neoplasms 30 HER2-positive Breast Cancer 19 Neoplasms 16 Breast Neoplasms, Male 16 Brain Neoplasms 13 Inflammatory Breast Neoplasms 12 Esophageal Neoplasms 10 Colorectal Neoplasms 10 Triple Negative Breast Neoplasms 8 Adenocarcinoma 7 Prostatic Neoplasms 6 Cardiotoxicity 6 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Lung Neoplasms 5 Carcinoma, Ductal, Breast 5 Biliary Tract Neoplasms 5 Salivary Gland Neoplasms 4 Pathologic Complete Response 4 Pancreatic Neoplasms 4 Meningeal Neoplasms 4 Colonic Neoplasms 4 Breast Diseases 4 Recurrence 3 Rectal Neoplasms 3 Meningeal Carcinomatosis 3 Gallbladder Neoplasms 3 Carcinoma, Lobular 3

Interventions

Radiotherapy 2 Radiosurgery 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 Drug Therapy 2 sacubitril and valsartan sodium hydrate drug combination 1 icotinib 1 dostarlimab 1 beta Carotene 1 avelumab 1 alpha-Tocopherol 1 Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Thalidomide 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Semen Analysis 1 Registries 1 Probiotics 1 Patient Reported Outcome Measures 1 Panitumumab 1 Nicotine Chewing Gum 1 Myofascial Release Therapy 1 Megestrol Acetate 1 Isotretinoin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms, Second Primary × Trastuzumab × Clear all

NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡